Suppr超能文献

丙泊酚静脉麻醉用于癌症患儿的疼痛性操作。

Intravenous anesthesia with propofol for painful procedures in children with cancer.

作者信息

Jayabose S, Levendoglu-Tugal O, Giamelli J, Grodin W, Cohn M, Sandoval C, Ozkaynak F, Kubal K, Nosetti M, Uman J, Visintainer P

机构信息

Section of Pediatric Hematology-Oncology, New York Medical College, Valhalla 10595, USA.

出版信息

J Pediatr Hematol Oncol. 2001 Jun-Jul;23(5):290-3. doi: 10.1097/00043426-200106000-00011.

Abstract

OBJECTIVE

To study the safety and efficacy of propofol-based intravenous anesthesia in children with cancer undergoing painful procedures.

METHODS

This study is a retrospective analysis of data collected from 52 consecutive children who underwent 335 procedures using propofol anesthesia. These data were routinely collected in all patients: time to induction, duration of the procedure, time to recover, and the doses of the drugs used. Monitoring with electrocardiography and pulse oximetry was continuous during the procedure; blood pressures were recorded before and after the procedure and every 5 to 10 minutes during the procedure. The patients received one of these four propofol-based intravenous regimens according to the anesthesiologist's preference: propofol only; propofol plus fentanyl; propofol plus midazolam; or propofol, fentanyl, and midazolam. The efficacy of sedation was rated by this scoring system: 3 = no movement during procedure; 2 = minimal movement that did not interfere with the procedure; 1 = moderate movement requiring physical restraint to complete the procedure.

RESULTS

There were six episodes of mild hypoxia (oxygen saturation 85%-94%) and one episode of laryngospasm. None required intubation. Two patients had agitation and one patient had emesis during the postrecovery phase. There was no difference in the efficacy of sedation between the four regimens. Patients receiving the combination of propofol, fentanyl, and midazolam received the least amount of propofol and required the least time to recover. There were no life-threatening complications.

CONCLUSIONS

Propofol-based anesthesia, when administered by an anesthesiologist in a controlled setting, is safe and effective for performing painful procedures in children with cancer.

摘要

目的

研究丙泊酚静脉麻醉用于癌症患儿进行疼痛性操作时的安全性和有效性。

方法

本研究是对连续52例使用丙泊酚麻醉进行335次操作的患儿收集的数据进行回顾性分析。这些数据在所有患者中常规收集:诱导时间、操作持续时间、恢复时间以及所用药物剂量。操作过程中持续进行心电图和脉搏血氧饱和度监测;操作前后及操作过程中每5至10分钟记录血压。根据麻醉医生的偏好,患者接受以下四种基于丙泊酚的静脉给药方案之一:仅丙泊酚;丙泊酚加芬太尼;丙泊酚加咪达唑仑;或丙泊酚、芬太尼和咪达唑仑。镇静效果通过以下评分系统进行评估:3分 = 操作过程中无活动;2分 = 有轻微活动但不干扰操作;1分 = 有中度活动需要身体约束才能完成操作。

结果

有6次轻度低氧发作(血氧饱和度85%-94%)和1次喉痉挛发作。均无需插管。两名患者在恢复后期出现躁动,一名患者出现呕吐。四种给药方案在镇静效果上无差异。接受丙泊酚、芬太尼和咪达唑仑联合用药的患者丙泊酚用量最少,恢复所需时间最短。无危及生命的并发症。

结论

在麻醉医生的控制下进行基于丙泊酚的麻醉,对于癌症患儿进行疼痛性操作是安全有效的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验